Telmisartan + Metoprolol Succinate ER Tablets Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a trusted Telmisartan + Metoprolol Succinate ER Tablets Manufacturer in India producing extended-release antihypertensive formulations for heart rate regulation and long-term cardiovascular management.

The formulation is commonly prescribed in hypertension associated with elevated cardiac workload and rapid heart rate conditions requiring sustained beta blocker and angiotensin receptor blocker therapy support. The company also operates as a Beta Blocker ARB Combination Tablets Exporter for regulated international pharmaceutical markets.

Genliva Wellness LLP additionally serves as a Heart Rate Control Medicine Supplier offering cardiovascular contract manufacturing, private labeling, and export supply services for global healthcare distributors and pharmaceutical companies.

Telmisartan + Metoprolol Succinate ER Tablets are formulated for extended cardiovascular and antihypertensive therapy.

Extended-release cardiovascular combination formulation
Frequently utilized in hypertension management
Supports heart rate and vascular pressure control
Helps reduce cardiac workload stress

This formulation is prescribed in cardiovascular management therapies.

Treatment of hypertension conditions
Management of elevated heart rate conditions
Administered in cardiovascular therapy protocols

Telmisartan + Metoprolol Succinate ER Tablets deliver sustained cardiovascular support for hypertension management.

Valuable in heart rate control management
Frequently preferred in combination antihypertensive therapy
Effective extended-release cardiovascular support
Useful in long-term heart care management
Convenient once-daily oral administration
Maintains reliable blood pressure control performance